Aging Mammary Stem Cells and Breast Cancer Prevention

To examine whether rapamycin can reduce malignant markers and aberrant mammary
stem/progenitor cells (MaSCs) number in surgical specimens

Intervention

Rapamycin

Condition

Cancer of Breast

Investigators

LuZhe Sun, PhD, Ismail Jatoi, MD

See list of participating sites